What does long-term data show about biologic disc repair?

Long-term follow-up data on intra-annular fibrin injection shows that a substantial portion of patients with disc-related chronic low back pain experience durable pain reduction and improved function at two or more years post-treatment — without surgery. A clinical evaluation is the only way to know whether the procedure is appropriate for a specific patient’s anatomy and history.

What did the long-term outcome study find?

Prospective observational data tracking patients over multi-year follow-up periods has produced several consistent findings worth understanding.

• Pain score improvement: Among the most-tracked outcomes, VAS pain scores moved from a baseline of 72.4 mm to 33.0 mm at 104 weeks — a clinically meaningful reduction. Individual outcomes vary.
• Patient satisfaction: 70% patient satisfaction was recorded at two or more years of follow-up, according to long-term outcome registry data. Individual outcomes vary.
• Patients with prior surgery: 80% of patients who had undergone failed prior spinal surgery reported positive outcomes with fibrin injection, per outcome registry data. Individual outcomes vary.
• Overall procedure volume: More than 13,000 of these procedures have been performed nationally, providing a substantial dataset for evaluating safety and outcomes.

Participants in tracked cohorts had typically experienced chronic low back pain for at least six months and had not achieved lasting relief from physical therapy, medications, or epidural injections. The data tracked pain scores, functional status, and the need for subsequent surgical intervention.

How does the fibrin procedure work?

The intra-annular fibrin injection is a minimally invasive, imaging-guided procedure designed to seal tears in the annulus fibrosus — the outer ring of an intervertebral disc — using an FDA-approved fibrin sealant.

Here is how the clinical process works at a high level:

1. Annulogram (diagnostic step): Before any treatment, an imaging-guided annulogram identifies every tear and leak in the discs under evaluation. This step is essential — treatment is guided by what the annulogram reveals, not by MRI alone.
2. Fibrin injection (treatment step): The FDA-approved fibrin sealant is delivered through a thin catheter into the compromised disc under imaging guidance. The procedure takes under one hour, uses local anesthesia or light sedation, and requires no incisions.

The fibrin sealant used in the procedure is FDA-approved as a sealant. Specific clinical applications, candidacy, and outcomes vary by patient. The intended mechanism is to seal annular tears, reduce internal disc leakage, and create an environment that supports structural stabilization of the disc.

Why does this approach represent a different path than surgery?

For patients with chronic disc-related back pain who have not responded to conservative care, the standard pathway has historically led toward surgery — most often spinal fusion or discectomy. Those procedures address mechanical instability but carry significant recovery demands, and back surgery carries roughly a 40% failure rate according to Failed Back Surgery Syndrome literature.

The fibrin procedure targets the underlying disc pathology — the annular tear — rather than removing or fusing spinal structures. It is not appropriate for every patient, and a clinical evaluation is required to determine candidacy. But for patients who are appropriate candidates, it represents a different category of intervention: one that works with the disc’s anatomy rather than replacing it.

For context on how this approach compares with other non-surgical options, see 7 Best Spinal Fusion Alternatives in 2026 and Spinal Fusion Alternatives: Treatment Options & Decision FAQ.

Who typically pursues biologic disc repair?

The profile of patients who go on to pursue the fibrin procedure tends to share several characteristics:

• Chronic back or neck pain with a documented disc-related cause (annular tears, disc degeneration, herniation)
• At least six months of conservative care — physical therapy, medications, epidural injections — without durable relief
• Unwillingness or inability to accept surgical fusion as the next step
• In some cases: prior spine surgery that did not resolve pain (Failed Back Surgery Syndrome)

A clinical evaluation — including MRI review and, when appropriate, annulogram — is the only way to determine whether a specific patient’s disc anatomy and history make them an appropriate candidate. Valor offers a no-cost MRI review as an initial step.

For a detailed look at candidacy criteria, see Am I a Candidate for Spinal Fusion Alternatives? Frequently Asked Questions.

What does the evidence show about other non-surgical treatments?

Understanding how the fibrin procedure fits into the broader landscape requires an honest look at what other common treatments have demonstrated:

• Epidural steroid injections: An AAFP systematic review found them not effective for chronic low back pain as a durable intervention.
• PRP (platelet-rich plasma): 47% of patients achieved 50% or greater pain relief at six months, per a PRP outcomes meta-analysis.
• Spinal decompression therapy: 36.8% showed sustained improvement at six months, per available outcomes data.

These figures are population statistics. Individual outcomes vary across all treatment categories, and no treatment produces the same result for every patient. The role of a thorough clinical evaluation is to match the appropriate treatment to the appropriate patient — not to recommend any single approach universally.

See also: 11 Common Spine Treatment Mistakes Patients Make Before Surgery.

How does this apply to veterans with chronic back pain?

65.6% of veterans report pain in the past three months, according to VA epidemiological data — and chronic disc-related back pain is among the most common complaints. Many veterans have been through multiple rounds of physical therapy, pain management, and medication at VA facilities without lasting relief, and some have been told fusion is the only remaining option.

Under the Mission Act, the intra-annular fibrin injection may be a covered VA benefit when the VA cannot provide timely or appropriate care. VA coverage is determined case-by-case under Mission Act criteria by the VA, not by Valor Spine. Valor coordinates the referral process directly with VA referral coordinators — including paperwork, prior authorization support, and coordination of patient and approved caregiver travel when applicable. Veterans do not have to navigate that process alone.

What should a patient do next if they are considering this option?

The practical next step is a consultation and, where applicable, a no-cost MRI review. A clinician can evaluate whether the disc pathology shown on imaging is consistent with annular tear-related pain and whether the history supports candidacy for the fibrin procedure. No commitment to treatment is required at the consultation stage.

For patients who have already had a prior spine surgery that did not fully resolve their pain, see How to Avoid Spinal Fusion Surgery: A Patient’s Step-by-Step Guide and What Is Spinal Fusion? Procedure, Risks, and Non-Surgical Alternatives for additional context on the decision framework.

Frequently Asked Questions

Is the fibrin sealant used in the procedure FDA-approved?

The fibrin sealant used in the intra-annular fibrin injection is FDA-approved as a sealant. Specific clinical applications, candidacy, and outcomes vary by patient.

How many of these procedures have been performed?

More than 13,000 intra-annular fibrin injection procedures have been performed nationally, according to manufacturer and procedure registry data. Among those with long-term follow-up data — over 7,000 procedures — the tracked success rate is 83%. Individual outcomes vary.

Does the procedure require surgery or general anesthesia?

No. The procedure is performed under imaging guidance using a thin catheter, requires no incisions, and uses local anesthesia or light sedation. It typically takes under one hour. It is a minimally invasive outpatient procedure.

Who is not a candidate for biologic disc repair?

Patients with acute spinal fractures, spinal tumors, neurological emergencies such as cauda equina syndrome, or pain unrelated to disc pathology are outside the scope of this procedure. A clinical evaluation is the only way to determine candidacy for any specific patient.

Can veterans access this procedure through the VA?

Under the Mission Act, the procedure may be a covered VA benefit when the VA cannot provide timely or appropriate care. VA coverage is determined case-by-case by the VA. Valor Spine works directly with VA referral coordinators to manage the process on the veteran’s behalf.

What is an annulogram and why does it matter?

An annulogram is an imaging-guided diagnostic procedure that identifies every tear and leak in the spinal discs before treatment. It is a critical step because MRI alone does not always reveal the full picture of disc pathology. Treatment planning for the fibrin procedure is based on annulogram findings, not MRI alone.

How long do the results last?

Long-term outcome registry data tracks patients at two or more years post-procedure. At that interval, 70% patient satisfaction is recorded and VAS pain scores show sustained reduction from baseline. Individual outcomes vary, and no outcome can be guaranteed for any specific patient.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.